Current Price Targets For Voyager Therapeutics, Inc. (NASDAQ:VYGR)

http://newsden.net/analysts-price-targets/current-price-targets-for-voyager-therapeutics-inc-nasdaqvygr/102049

. . . the report mentions

" . . . a monogenic form of amyotrophic lateral sclerosis (ALS) . . ." as a disease targeted by their research.